Palvella Therapeutics Inc
PVLA
NASDAQ
Biotechnology
$156.13
USD
-0.42 (-0.27%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $2.24B
Volume 109.8K
Price Target
$220.00 – $240.00
USD
The 2 analysts offering 1-year price forecasts have a max estimate of $240.00 and a min estimate of $220.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$230.00
-$9.0 vs prior
Implied Upside
+47.3%
-5.8% vs prior
Analyst Covering
2
-3 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
29%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
2 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
2 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Geulah Livshits | Chardan Capital | Buy | Maintained | 2 months ago | Plus | Plus | Plus |
Sudan Loganathan | Stephens & Co. | Buy | Reiterated | 2 months ago | Plus | Plus | Plus |
Frequently Asked Questions
